Peptide market boom attracts venture capital as Bay Area entrepreneurs race to capitalize on potential FDA approval.
|
San Francisco's entrepreneurs find themselves at the leading edge of an emerging— and potentially lucrative—wellness market: compounded peptide drugs. The city's technology community has turned casual group discussions about peptide wellness tips into serious, all-business development; and, startups, VCs and aspiring founders are all racing to capture as much peptide market share as they can before any potential federal government approval is received this summer.
Recently, momentum around this trend culminated in the inaugural meeting of the California Peptide Club, hosted by 24-year-old entrepreneur and AGI House president Julius Ritter—who owns a multimillion-dollar mansion in San Francisco's Twin Peaks neighborhood that serves as home to a large cohort of aspiring AI entrepreneurs. Around 110 people, primarily Gen Z and Millennial professionals, attended the event where industry panelists shared their "stacks" of personal peptide use, and debated commercial potential for various peptide-related products. The anecdote illustrates a shift in conversation around peptides in San Francisco: previously, the question was "What are you taking?” now, it is "What are you building?" Peptides are short chains of amino acids that prompt the body to perform specific functions, including hormone regulation, tissue repair, etc. Examples include insulin and Ozempic. Many peptides currently featured in the burgeoning wellness trend (e.g., retatrutide—currently undergoing Phase 3 trials at Eli Lilly—and BPC-157) are not yet approved by the FDA.
The term "research use only" is applied to peptides that cannot be legally sold to humans because they are not classified as safe by the FDA, but this has become an accepted way to get around those laws in the peptide business. Health and Human Services Secretary Robert F. Kennedy Jr., criticized the FDA for not classifying 19 peptides as safe during an appearance on "The Joe Rogan Experience", and pledged to make these products more available to patients. Two months later, the FDA announced it had removed 12 of those peptides from its "do not compound" list and would hold a review hearing in July about whether to allow compounding of the remaining 7. Although nothing legally has changed, many entrepreneurs interpreted this announcement as an invitation to begin selling peptides anyway, betting they will be able to build their businesses faster than the regulatory processes will allow.
Financial incentives in this case are enormous. Healthcare lawyers say they receive an average of 5 to 10 inquiries per day from potential "pep-treneurs" who want to be suppliers, prescribers or build infrastructure in the peptide space. One attorney described the rush as similar to the gold rush in California. Interest in peptides has increased dramatically, with the number of Google searches for 'peptide' now greater than the combined number of searches for 'pickleball', 'matcha', and 'boba'. Many celebrities, including country singer LeAnn Rimes have disclosed they use peptide injections daily.
Business Honor is of the view that peptide market deregulation represents a transformative opportunity for Bay Area startup founders and venture capitalists.
FAQsQ: What are peptides? A: Peptides are short chains of amino acids that signal the body to perform specific biological functions like hormone regulation. Q: Why are San Francisco startups interested in peptides? A: Entrepreneurs see potential FDA approval this summer as a first-mover advantage opportunity in an emerging wellness market. Q: Are peptides currently legal to sell? A: Most peptides lack FDA approval and are marketed as "research use only," existing in legal limbo for human consumption. Q: What health risks do unapproved peptides pose? A: Medical experts warn of quality variability, contamination, unclear dosing, autoimmune reactions, and absence of long-term safety data. Q: Where do most peptides come from? A: The majority of peptides originate in China, where quality control and transparency regarding purity remain significant concerns. Q: What triggered the current peptide boom? A: RFK Jr.'s February criticism of FDA peptide restrictions and the FDA's subsequent removal of 12 peptides from its "do not compound" list. Q: How much interest is there in peptides? A: Google searches for peptides now exceed searches for pickleball, matcha, and boba combined, indicating massive mainstream interest. Q: Are celebrities using peptides? A: Yes, country singer LeAnn Rimes publicly disclosed she gives herself daily peptide injections as part of her wellness routine. |
.webp)
